In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor  by Breyer, Matthew D. et al.
Kidney International, Vol. 43 (1993), pp. 1372—1378
RAPID COMMUNICATION
In situ hybridization and localization of mRNA for the rabbit
prostaglandin EP3 receptor
MATTHEW D. BREYER, HARRY R. JACOBSON, LINDA S. DAVIS, and RICHARD M. BREYER
Department of Veterans Affairs Medical Center, and Division of Nephrology and Department of Medicine, Vanderbilt University, Nashville,
Tennessee, USA
In situ hybridization and localization of mRNA for the rabbit pros-
taglandin EP3 receptor. The physiological effects of POE2 appear to be
mediated by at least three different "E-prostanoid" receptors desig-
nated EP1, EP2, and EP3. These receptors are differentially activated by
structural POE analogs (such as misoprostol) and each couples to a
different signal transduction mechanism. Studies demonstrating that
inhibition of water absorption in the collecting duct is mediated by a 0,
coupled mechanism, suggests that an EP3 receptor is involved the renal
effects of POE2. We used in situ hybridization to determine the tissue
distribution of the rabbit EP3 receptor. [a-35S] UTP labeled antisense
RNA, comprising transmembrane domains IV through VII, was hybrid-
ized to tissue sections. Specific labeling of kidney, stomach and adrenal
was observed. In the kidney, medullary thick ascending limb and
cortical and medullary collecting ducts were intensely labeled, while no
labeling of glomeruli, proximal tubules, or cortical thick ascending
limbs was observed. The adrenal gland labeled exclusively in the
medulla. In the stomach the gastric epithelial crypts were the predom-
inant site of hybridization, without evidence of labeling of the smooth
muscle. These results suggest an important role for the EP3 receptor in
mediating POE2 effects in these tissues.
Prostaglandin E2 (POE2) modulates an impressive array of
physiologic responses. These effects include regulation of vas-
cular tone, adrenal catecholamine release, gastric acid secre-
tion, and modulation of renal salt and water transport. In the
kidney, POE2 modulates glomerular hemodynamics [1—3], in-
hibits Na transport in the thick ascending limb [4, 51, and
inhibits both water and Na transport in the collecting duct
[6—9]. Under some circumstances its cellular effects appear to
be self-opposing. For instance, when administered to the iso-
lated perfused cortical collecting duct, PGE2 stimulates water
permeability and cyclic AMP generation [8, 10, 11], however,
when administered to vasopressin pretreated collecting ducts
POE2 inhibits water permeability and cyclic AMP generation [8,
10, 11]. Similarly POE2 has been shown to vasodilate certain
vascular beds while it constricts other vascular beds [12—14].
These self-opposing effects of POE2 appear to be mediated by
separate classes of POE2 receptors [15].
To date three receptor POE2 subtypes have been proposed,
and designated as "E-prostanoid" receptors: EP1, EP2 and
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EP3. Each is selectively activated by specific structural analogs
of POE2 and is coupled to a different signal transduction
mechanism. In the past year nucleotide sequences for the EP3
and EP2 receptor subtypes have been reported [16, 17]. The EP3
receptor couples to an inhibitory G-protein (Ge) and inhibits
cAMP generation while the EP2 receptor couples to 0. and
stimulates cAMP generation. The EP1 receptor is thought to
couple to phosphatidylinositol hydrolysis [18]. The existence of
multiple POE2 receptors may account for its diverse effects.
The precise EP receptor subtype mediating the effects of
POE2 in the kidney and other target tissues remains unclear.
We have recently cloned and expressed the rabbit EP3 receptor.
Those studies demonstrated especially high levels of expression
in the rabbit kidney, adrenal and stomach [19]. The purpose of
the present studies was to localize this receptor subtype in these
tissues.
Methods
Generation of antisense RNA fragments
For generation of antisense RNA probes, a fragment com-
prising nucleotides 565 to 1022 of the coding region of the rabbit
EP3 receptor [19] was amplified by PCR and ligated in the
transcription vector pCRII. This region corresponds to amino
acids comprising the fourth transmembrane domain to the
seventh transmembrane domain. This region is common to all
four of the cloned EP3 subtypes [19]. The plasmid was linear-
ized and antisense RNA was transcribed from the flanking T7
promoter in the presence [a-35S] UTP essentially as described
[20]. Antisense RNA (5 x l0 cpm/d) was used for in situ
hybridization.
Tissue preparation. Female New Zealand white rabbits
weighing between 1.5 and 2 kg were anesthetized using intra-
muscular ketamine and xylazine (44 mg and 10 mg/kg, respec-
tively). After surgical anesthesia was achieved, rabbits were
sacrificed by decapitation and kidney, stomach, and adrenal
were harvested. Tissues were fixed in 4% paraformaldehyde.
The only exception to this were the kidneys which we initially
perfused with a 1% paraformaldehyde-phosphate buffered sa-
line prior to immersion in 4% paraformaldehyde. Tissues were
imbedded in paraffin and 7 zm sections were cut.
Prior to hybridization sections were deparaftinized, re-fixed
in paraformaldehyde and treated with proteinase K (20 g/ml),
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washed with phosphate buffered saline, refixed in 4% paraform-
aldehyde, and treated with triethanolamine plus acetic anhy-
dride (0.25% vol/vol). Finally sections were dehydrated to 100%
ethanol.
Anti-sense RNA was hybridized to the sections at 50 to 55°C
for approximately 18 hours as described by Pelton et al [21].
Following hybridization sections were washed at 50°C in Sx
SSC + 10 mM 13-mercaptoethanol for 30 minutes. This was
followed by a wash in 50% formamide, 2x SSC, and 100 mri
13-mercaptoethanol for 60 minutes. Following additional washes
in 10 mM TRIS, 5mM EDTA, 500 mri NaCI (TEN), sections
were treated with RNase (10 tg/m1), for 37°C, 30 minutes,
followed by another wash in TEN (37°C). Sections were then
washed twice in 2x SSC; and twice in 0.1x SSC (50°C). Slides
were dehydrated with graded ethanols containing 300 mr.i
ammonium acetate.
For detection of the hybridized probe, slides were dipped in
photoemulsion (Ilford KS, Knutsford, UK) diluted 1:1 with 2%
glycerol/water and exposed for seven days at 4°C. After devel-
opment in Kodak D19, slides were counterstained with hema-
toxylin and eosin. Photomicrographs were taken using a Zeiss
Axioskop using both bright and dark field optics.
Immunostaining
To define the nephron segments which labeled for EP3
receptor RNA, in situ hybridization was followed by immuno-
staining of the tissue sections with an mouse monoclonal
anti-collecting duct antibody [22] or a goat anti-human Tamm-
Horsfall antibody, which specifically recognizes medullary and
cortical thick ascending limb as well as the early portion of the
distal tubule [23]. Tissue sections were incubated with serial
dilutions of the anti-collecting duct or Tamm-Horsfall antibody
(1:250, 1:1,000, 1:1,500, and 1:2,000). Immunolabeling was
detected using either a biotinylated rabbit anti-goat or rabbit
anti-mouse secondary antibody followed by visualization with
an avidin-biotin horseradish peroxidase labeling kit (Vectastain
ABC kit) and diaminobenzidine staining.
Autoradiography
In some cases the radiolabeled probe was detected by auto-
radiography rather than a photo-emulsion. For these studies the
probe was allowed to hybridize to the tissue sections and
following extensive washing the tissue was apposed to Kodak
ANTI-SENSE
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Fig. 1. Autoradiograms of kidney (k),
stomach (s), and adrenal (a) sections after
hybridization with [a-35S]UTP labeled EP3
receptor anti-sense or sense RNA.
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Fig. 2. Photomicrographs of in situ hybridization of kidney sections for EP3 receptor mRNA. A and B show 50x darkfield photomicrographs of
rabbit kidney cortex and medulla respectively (the white and pink areas are the labeled structures). In A, the arrow is pointing along a line of
unlabeled glomeruli. In figure B, OM is outer medulla and IM is inner medulla (papilla). C and D show 400x brightfield photomicrographs of cortex
and medulla, respectively. The black grains indicate positive labeling for EP3 receptor. The brown reaction indications positive staining with a
mouse monoclonal anti-collecting duct antibody. Both cortical and medullary collecting ducts are labeled. E and F show 400X bright field
photomicrographs of cortex and medulla respectively. The brown precipitate indicates positive staining with a goat anti-human Tamm-Horsfall
antibody. In the cortex EP3 mRNA was not detected in the thick limb (Tamm-Horfall positive), while in the medulla both Tamm-Horsfall positive
and Tamm-Horsfall negative tubules were labeled. G shows a bOx simultaneous brightfield/darkfield photomicrograph demonstrating different
distribution of the EP3 receptor mRNA (in situ grains appear white) and Tamm-Horsfall immunoreactivity (appears orange) in the renal cortex. H
The arrows point to labeling of a tubule subpopulation in the cortex which is negative for both collecting duct markers (brown staining tubules)
and, as shown in 2G, negative for thick limb markers. These tubules may represent distal convoluted tubule or connecting segment. Publication
of this figure in color was made possible by an educational grant from Merck and Company, Human Health DivisiQn.
(XAR) film at 4°C for one week. The film was then developed in
an automatic film processor.
Results
Autoradiography
Autoradiograms of kidney, stomach and adrenal showed
specific labeling with anti-sense but not sense EP3 receptor
RNA fragments (Fig. 1). Intense labeling of kidney, stomach,
and adrenal was observed. In the kidney the most intense
labeling was detected over the outer medulla. There was
punctate labeling of the cortex and no detectable labeling of the
inner medulla, Similarly hybridization to the adrenal gland
showed selective localization over the adrenal medulla with no
detectable hybridization over the adrenal cortex. Autoradio-
grams of the stomach suggested labeling primarily over the
gastric epithelium rather than the smooth muscle.
Photo-microscopy
Kidney. Intense labeling of most tubules in the renal outer
medulla was observed. Figure 2 shows that labeling included
both Tamm-Horsfall and anti-collecting duct antibody positive
tubules, demonstrating both outer medullary collecting duct
and medullary thick ascending limb express EP3 mRNA. There
was no evidence hybridization of the EP3 antisense fragment to
the proximal straight tubules in the outer medulla. No labeling
of papillary or inner medullary structures was observed.
Hybridization of the EP3 probe to the renal cortex was less
intense than the renal outer medulla. Tamm-Horsfall positive
tubules in the cortex were not labeled. Labeling in the cortex
primarily involved the superficial cortical collecting duct as was
confirmed by co-staining with a monoclonal antibody to collect-
ing duct (Fig. 2 C and D). There also appeared to be a
subpopulation of labeled cortical tubules which did not stain for
either thick limb or collecting duct specific markers (Fig. 2H).
This suggests labeling of either the distal convoluted tubules or
connecting segment. No labeling of proximal tubules or glomer-
uli was detected.
Adrenal. The EP3 probe showed intense labeling of adrenal
chromaffin cells of the adrenal medullae. No specific labeling of
cells in the adrenal cortex was seen (Fig. 3).
Stomach. Intense labeling of the gastric epithelium seen. This
labeling was localized to the gastric crypts. The most superficial
epithelium was unlabeled. No specific labeling of smooth mus-
cle was observed (Fig. 3).
Discussion
It now appears that the disparate, and sometimes opposing
effects of POE2, both at the signal-transduction and functional
levels, are mediated by multiple receptors [14, 15]. These
E-prostanoid (EP) receptors, have been classified as EP1, EP2
and EP3. The cloned murine EP3 receptor demonstrates dis-
crete coupling to G1, and inhibition of cAMP generation,
without stimulation of inositol phosphate generation or cAMP
accumulation [16]. More recently a putative mouse EP2 recep-
tor has been identified and shown to selectively stimulate cAMP
generation [17]. The EP1 receptor is thought to selectively
stimulate phosphatidylinositol hydrolysis and increase intracel-
lular calcium [18, 24].
Although it is well established that PGE2 modulates function
in the kidney [3, 10, 25], stomach [26, 27], and adrenal gland
[28], the specific EP receptor isotype mediating these effects is
unclear. Many of these functional effects of PGE2 have been
described in the rabbit [5, 11, 26, 27, 29, 30]. The present
studies suggest the effects of POE2 on these rabbit tissues may
involve an EP3 receptor.
EP3 receptor mRNA was expressed in the medullary thick
ascending limb but was not detected in the cortical thick
ascending limb. EP3 mRNA was also expressed in both medul-
lary and cortical collecting duct. No specific hybridization of
EP3-antisense RNA to glomeruli or proximal tubules was noted.
The labeling of medullary but not cortical thick ascending limb
is consistent with the studies of Stokes, who found that POE2
inhibits chloride absorption in the rabbit medullary thick as-
cending limb but had no effect on chloride transport in the
cortical thick ascending limb of Henle [5]. Some studies have
suggested an EP3 receptor may be present in the rat cortical
thick ascending limb [31, 32], however, significant differences in
the hormonal regulation of nephron function exist between the
rat and rabbit (including differing effects of PGE2) [23, 33] so
EP3 receptor may be expressed in the cortical thick ascending
limb of the rat but not the rabbit. Alternatively, and despite
studies showing inhibition of transport in the medullary but not
cortical thick ascending limb [5], other studies found no differ-
ence in the effects of PGE2 on cAMP metabolism in the cortical
and meduallary thick limb [34]. Of note, these latter studies,
were limited to the juxtamedullary portion of the thick limb [34,
35], possibly accounting for this discrepancy, whereas the
microdissection studies included the entire cortical thick limb.
While we cannot exclude the presence of low levels of EP3
mRNA in the cortical thick ascending limb, it seems clear that
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Fig. 3. Stomach and adrenal. In the 50x darkfield photomicrograph of the stomach (A) the white grains indicate areas positive for EP3 mRNA.
B shows the same area of stomach under brightfield illumination. C and D show 400x simultaneous brightfield and darkfield illumination of gastric
epithelium. In C the white grains demonstrates labeling of the crypts. In D darkfield illumination was decreased so the histologic features could
be more clearly distinguished. E and F show the adrenal. E is a 50x darkfield photomicrograph where the white grains depicting positive labeling
of the adrenal medulla. F is a 400x brightfield photomicrograph of the junction between adrenal medulla (M) and cortex (C). The black grains
indicate the presence of EP3 mRNA in the adrenal medulla. Publication of this figure in color was made possible by an educational grant from
Merck and Company, Human Health Division.
the expression of this message is markedly less than in the
mTAL, CCD or OMCD. The similarity between the functional
effects of PGE2 in microdissected rabbit cortical and medullary
thick ascending limb, and the distribution of EP3 mRNA along
the thick ascending limb, suggests that the EP3 receptor may
play an important role in mediating the effects of PGE2 on C1
transport in the mTAL.
Similarly the presence of EP3 receptor mRNA in cortical and
medullary collecting duct is consistent with previous studies
demonstrating that the EP1/EP3 selective prostaglandin analog,
sulprostone, potently inhibits vasopression stimulated water
permeability and cAMP generation in the rabbit cortical collect-
ing duct [11, 22, 29, 36]. Interestingly, there appeared to be a
gradient for the intensity of EP3 mRNA along the collecting
duct, with greater levels of expression in the superficial, rather
than the deep CCD. There was also substantial expression of
EP3 mRNA in the outer medullary collecting duct but little
labeling of the papillary collecting duct. These observations are
consistent with autoradiographic mapping of PGE2 binding sites
in human and rat kidney where specific [3H]-PGE2 binding was
primarily observed in the outer medulla [37, 38] including the
collecting duct and thick ascending limb. In agreement with the
present studies, no [3H]-PGE2 binding to glomeruli or proximal
tubule was seen. These [3H]-PGE2 binding studies did not
address which EP receptor subtype(s) accounted for binding.
The present studies suggest an EP3 receptor may constitute the
majority of these binding sites. In agreement with this possibil-
ity are biochemical studies suggesting that the major PGE2
receptor in canine renal medulla is coupled to G. [39]. Explicit
examination of the distribution of the EP3 receptor protein will
have to await the development of EP3 receptor-specific anti-
bodies.
The present studies also suggest an important role for the EP3
receptor in modulating gastric and adrenal function. PGE2
stimulates catecholamine release in the adrenal medulla. This
mechanism appears to involve both pertussis toxin insensitive
phosphatidylinositol hydrolysis and pertussis toxin sensitive G,
coupled mechanisms [28]. The latter mechanism is consistent
with a functional role for the EP3 receptor in modulating
catecholamine release from the adrenal medulla. Similarly,
while specific PGE2 binding sites have been identified in rabbit
gastric glands [27] the EP receptor subtype which mediates its
effects on acid secretion has not been characterized. Activity of
PGE2 analogs, such as misoprostol, in peptic ulcer disease
depend on the nature of the EP receptor coupled to this
functional effect. PGE2 inhibits acid secretion by rabbit gastric
glands via a pertussis toxin sensitive mechanism, coupled to the
inhibition of cAMP generation [26]. Together with the present
studies demonstrating the existence of EP3 messenger RNA in
gastric epithelial cells, these observations strongly suggest an
important role for the EP3 receptor in mediating PGE2's effects
on gastric acid secretion.
In summary the present studies demonstrate high levels of
expression of the mRNA for the EP3 receptor in renal and
gastric epithelia. This distribution of EP3 receptor mRNA
corresponds to the nephron segments where PGE2 has been
demonstrated to inhibit NaCI and water transport. High levels
of EP3 receptor mRNA were also present in the adrenal
medulla. Characterization of EP receptor subtype tissue distri-
bution should help predict the physiologic consequences of
their activation, and should help guide the therapeutic uses of
receptor selective PGE2 analogs, as they become increasingly
available.
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